Faheem Hasnain, Director at Kura Oncology, Inc. (KURA), sold 22,682 shares at $8.00 ($181K) on 2025-03-21, disclosed to the SEC on 2025-03-24.
Open-market sale of $181k KURA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GOSS | SELL | 2024-03-28 | $27K | — | Filing → |
| MRTX | BUY | 2023-08-14 | $600K | — | Filing → |
| GOSS | BUY | 2023-03-22 | $2.0M | — | Filing → |